関連する実験動画

Updated: Feb 26, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

10.2K

構造ベースのドッキング研究と機能的検証を統合した新規VEGFR2阻害剤の発見：標的がん治療への応用可能性

Hussam Albassam1, Saad Alobid2, Faris Almutairi2

  • 1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, PO Box 2457, Riyadh, 11451, Kingdom of Saudi Arabia. halbassam@ksu.edu.sa.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
|February 24, 2026
PubMed
まとめ

研究者らは、がんの重要な標的である血管内皮増殖因子受容体2（VEGFR2）を阻害する新規化合物 を特定しました。この有望ながん治療薬候補は、腫瘍の増殖を抑制する可能性を示しており、さらなる開発が期待されます。

キーワード:
がん創薬構造ベースドッキング研究標的がん治療VEGFR2阻害剤VEGFR2シグナル伝達経路

さらに関連する動画

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K
Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

8.3K

関連する概念動画

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K